Company Filing History:
Years Active: 2010
Title: Anthony Christopher Lee Stevens: Innovator in Pancreatic Insufficiency Treatment
Introduction
Anthony Christopher Lee Stevens is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of medical treatments, particularly focusing on pancreatic insufficiency. His innovative approach has led to the development of a unique composition aimed at improving the quality of life for patients suffering from this condition.
Latest Patents
Stevens holds a patent for "Compositions and methods for treating pancreatic insufficiency." This invention relates to compositions that include lipase, protease, and amylase in a specific ratio that yields beneficial results for patients afflicted with pancreatic insufficiency. The compositions specifically comprise crosslinked lipase crystals, protease crystals, and amorphous amylase in a ratio of about 1:1:0.15 USP units. This patent highlights his commitment to advancing medical treatments and improving patient outcomes.
Career Highlights
Stevens is associated with Cystic Fibrosis Foundation Therapeutics, Inc., where he applies his expertise to develop innovative solutions for patients. His work in this organization underscores his dedication to addressing critical health issues and contributing to the advancement of medical science.
Collaborations
Some of his notable coworkers include Alexey L Margolin and Bhami Shenoy. Their collaboration reflects a team-oriented approach to innovation and research, which is essential in the field of medical advancements.
Conclusion
Anthony Christopher Lee Stevens is a distinguished inventor whose work in treating pancreatic insufficiency demonstrates his innovative spirit and commitment to improving healthcare. His contributions are paving the way for better treatment options for patients in need.